Edoardo Longarini receives the Peter Hans Hofschneider Prize

Prize for outstanding scientific work in the field of molecular medicin 

Edoardo Longarini, former PhD student at the Max Planck Institute for Biology of Ageing and the Cologne Graduate School of Ageing Research, has been awarded the prestigious Peter Hans Hofschneider Prize.

The Peter Hans Hofschneider Prize is awarded every two years by the Max Planck Society for outstanding scientific work in the field of molecular medicine and is endowed with 3,000 euros. This year's award ceremony took place during the annual meeting of the Max Planck Society in Magdeburg.

At the award ceremony, Edoardo was joined by his doctoral supervisor, Dr Ivan Matic, who paid tribute to his former doctoral student's career and scientific achievements in a laudatory speech. Dr Matic emphasised that Edoardo had developed innovative methods and made groundbreaking discoveries in the fields of PARP1 biology, ADP-ribosylation, chromatin research, and DNA damage response during his time as a doctoral student. This work has attracted considerable attention and is influencing new research projects at the Max Planck Institute for Biology of Ageing and beyond.

"I am honoured that my doctoral work has been recognised with this award and I am very grateful to my supervisor Dr Ivan Matic and the lab members for their support," said Edoardo Longarini.

During his doctoral studies, Longarini researched serine ADP-ribosylation, an important protein modification involved in DNA damage repair. He developed a new technique that enabled this research and demonstrated that there are two signalling waves in DNA repair.

Edoardo Longarini is currently working as an EMBO Postdoctoral Fellow in the laboratory of Prof Tom W. Muir at Princeton University (USA) on the topic of "Proteins in complex biological systems" and at the interface between cell biology, biochemistry and organic chemistry.